Following the landmark approval of imatinib 20 years ago, over 70 kinase inhibitors are now transforming the clinical care of multiple malignancies and a handful of other disorders.

中文翻译：

---

伊马替尼 20 年后发现激酶药物


继 20 年前伊马替尼获得里程碑式的批准之后，超过 70 种激酶抑制剂正在改变多种恶性肿瘤和少数其他疾病的临床护理。